Gyre Therapeutics, Inc. · NASDAQ:GYRE

Ye Weiguo sold 7,500 Gyre Therapeutics, Inc. shares (Form 4)

Traded May 22 to May 26, 2026 · Filed May 27, 2026

From May 22 to May 26, 2026, Ye Weiguo (Chief Operating Officer) sold 7,500 Gyre Therapeutics, Inc. shares at an average US$6.09 for US$45,680, leaving 700,000 shares. Filed May 27, 2026 (Form 4).

Sold: 7,500 shares
Price: US$6.09 average (US$6.08 to US$6.10)
Value: US$45,680
Holding after: 700,000 shares
Trading plan: No
Role: Chief Operating Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
May 22, 2026	Common Stock	Option exercise	3,500	US$0.75	703,500	Direct
May 22, 2026	Common Stock	Sale	3,500	US$6.08	700,000	Direct
May 26, 2026	Common Stock	Option exercise	4,000	US$0.75	704,000	Direct
May 26, 2026	Common Stock	Sale	4,000	US$6.10	700,000	Direct

Source

View original at SEC

Related